Smartphone maker HTC Corp (宏達電) has set its sights on earning an operating license from the Food and Drug Administration to commercialize a new medical virtual-reality (VR) product in the first quarter of next year.
Dubbed Surgical Theater, the VR product could begin to be adopted in clinical use and provide HTC with new revenue streams from the healthcare sector, the company said at a news conference yesterday.
The company also announced that it has sold Taipei Medical University its latest VR offering, 3D Organon, a bundle of 10 Vive Pro VR headsets that provide visualized anatomy information for education.
Photo by Kao Shih-ching, taipei Times
Medical students usually learn human anatomy from 2D models and diagrams in textbooks, or from donated cadavers, which are often in short supply, university Department of Anatomy professor Chang Hung-ming (張宏名) told the Taipei Times.
With the VR teaching system, students can see a computerized simulation that more clearly depicts human anatomy, especially the nervous system, whose components are thin and mostly hidden behind muscles and cavities, Chang said.
A 360o view allows users to see the human body from all angles to better understand how everything is connected, and they can also peel back layers or isolate 4,000 body parts to have a specific view, HTC healthcare division DeepQ director Jerry Cheng (鄭志偉) said.
“Users can even go through the virtual body to have a clear look inside at parts such as the spine and cavities,” he said.
However, it is hard for a VR system to substitute for “silent teachers” (大體老師) — people who have donated their bodies to medical schools — as “students cannot touch or feel the elasticity of muscles in virtual reality,” Chang said.
Besides Taipei Medical University, HTC has also sold 3D Organon to Tri-Service General Hospital and Taipei Municipal Wanfang Hospital, which plan to use the product for shared decisionmaking with patients, Cheng said.
While the firm has begun marketing 3D Organon, which costs about NT$100,000 per unit, HTC said it has also applied for a license for Surgical Theater, which would cost significantly more.
The company has received three medical appliance licenses from the US Food and Drug Administration for Surgical Theater, which provides accurate information that can even be used to help surgeons navigate operations, Cheng said.
As HTC has already conducted clinical trials in the US, it expects to receive approval from the Taiwanese agency by the first quarter of next year, Cheng said, adding that it would market the product to domestic hospitals first and expects to see revenue from the healthcare sector soar.
DIVIDED VIEWS: Although the Fed agreed on holding rates steady, some officials see no rate cuts for this year, while 10 policymakers foresee two or more cuts There are a lot of unknowns about the outlook for the economy and interest rates, but US Federal Reserve Chair Jerome Powell signaled at least one thing seems certain: Higher prices are coming. Fed policymakers voted unanimously to hold interest rates steady at a range of 4.25 percent to 4.50 percent for a fourth straight meeting on Wednesday, as they await clarity on whether tariffs would leave a one-time or more lasting mark on inflation. Powell said it is still unclear how much of the bill would fall on the shoulders of consumers, but he expects to learn more about tariffs
NOT JUSTIFIED: The bank’s governor said there would only be a rate cut if inflation falls below 1.5% and economic conditions deteriorate, which have not been detected The central bank yesterday kept its key interest rates unchanged for a fifth consecutive quarter, aligning with market expectations, while slightly lowering its inflation outlook amid signs of cooling price pressures. The move came after the US Federal Reserve held rates steady overnight, despite pressure from US President Donald Trump to cut borrowing costs. Central bank board members unanimously voted to maintain the discount rate at 2 percent, the secured loan rate at 2.375 percent and the overnight lending rate at 4.25 percent. “We consider the policy decision appropriate, although it suggests tightening leaning after factoring in slackening inflation and stable GDP growth,”
Greek tourism student Katerina quit within a month of starting work at a five-star hotel in Halkidiki, one of the country’s top destinations, because she said conditions were so dire. Beyond the bad pay, the 22-year-old said that her working and living conditions were “miserable and unacceptable.” Millions holiday in Greece every year, but its vital tourism industry is finding it harder and harder to recruit Greeks to look after them. “I was asked to work in any department of the hotel where there was a need, from service to cleaning,” said Katerina, a tourism and marketing student, who would
Meta Platforms Inc offered US$100 million bonuses to OpenAI employees in an unsuccessful bid to poach the ChatGPT maker’s talent and strengthen its own generative artificial intelligence (AI) teams, OpenAI CEO Sam Altman has said. Facebook’s parent company — a competitor of OpenAI — also offered “giant” annual salaries exceeding US$100 million to OpenAI staffers, Altman said in an interview on the Uncapped with Jack Altman podcast released on Tuesday. “It is crazy,” Sam Altman told his brother Jack in the interview. “I’m really happy that at least so far none of our best people have decided to take them
RSS